Literature DB >> 18715783

Unravelling the tumor-suppressive functions of FOXO proteins.

Tobias B Dansen1, Boudewijn M T Burgering.   

Abstract

Members of the forkhead box O (FOXO) family of transcription factors have been postulated to be tumor suppressors because of their established roles in cell-cycle arrest, apoptosis, DNA-damage repair and scavenging of reactive oxygen species. Recently, several animal model studies have shown that the FOXO proteins are indeed tumor suppressors. Furthermore, FOXO proteins have recently been implicated in the negative regulation of signaling by the hypoxia-inducible factor 1 during vascular development, raising the possibility that the FOXO proteins suppress not only tumor formation but also tumor angiogenesis and, possibly, metastasis. Here, we discuss recent advances in the understanding of the roles of FOXO family members in tumor suppression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18715783     DOI: 10.1016/j.tcb.2008.07.004

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  113 in total

Review 1.  Death and dessert: nutrient signalling pathways and ageing.

Authors:  Nazif Alic; Linda Partridge
Journal:  Curr Opin Cell Biol       Date:  2011-08-09       Impact factor: 8.382

2.  Identification of a mechanism underlying regulation of the anti-angiogenic forkhead transcription factor FoxO1 in cultured endothelial cells and ischemic muscle.

Authors:  Malgorzata Milkiewicz; Emilie Roudier; Jennifer L Doyle; Anastassia Trifonova; Olivier Birot; Tara L Haas
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex.

Authors:  J Wu; S-W Lee; X Zhang; F Han; S-Y Kwan; X Yuan; W-L Yang; Y S Jeong; A H Rezaeian; Y Gao; Y-X Zeng; H-K Lin
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

Review 4.  Adding more content to screening: reactivation of FOXO as a therapeutic strategy.

Authors:  Fabian Zanella; Amancio Carnero
Journal:  Clin Transl Oncol       Date:  2009-10       Impact factor: 3.405

5.  Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.

Authors:  Tihomir Miralem; Nicole Lerner-Marmarosh; Peter E M Gibbs; Jermaine L Jenkins; Chelsea Heimiller; Mahin D Maines
Journal:  FASEB J       Date:  2016-05-10       Impact factor: 5.191

6.  PKG inhibits TCF signaling in colon cancer cells by blocking beta-catenin expression and activating FOXO4.

Authors:  I-K Kwon; R Wang; M Thangaraju; H Shuang; K Liu; R Dashwood; N Dulin; V Ganapathy; D D Browning
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

7.  FOXO3 modulates endothelial gene expression and function by classical and alternative mechanisms.

Authors:  Tobias Czymai; Dorothee Viemann; Carsten Sticht; Grietje Molema; Matthias Goebeler; Marc Schmidt
Journal:  J Biol Chem       Date:  2010-02-01       Impact factor: 5.157

8.  Histone deacetylase inhibitors induce autophagy through FOXO1-dependent pathways.

Authors:  Jianbin Zhang; Shukie Ng; Jigang Wang; Jing Zhou; Shi-Hao Tan; Naidi Yang; Qingsong Lin; Dajing Xia; Han-Ming Shen
Journal:  Autophagy       Date:  2015-04-03       Impact factor: 16.016

Review 9.  From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis.

Authors:  Stavros C Manolagas
Journal:  Endocr Rev       Date:  2010-01-05       Impact factor: 19.871

10.  Protein phosphatase 2A reactivates FOXO3a through a dynamic interplay with 14-3-3 and AKT.

Authors:  Amrik Singh; Min Ye; Octavian Bucur; Shudong Zhu; Maria Tanya Santos; Isaac Rabinovitz; Wenyi Wei; Daming Gao; William C Hahn; Roya Khosravi-Far
Journal:  Mol Biol Cell       Date:  2010-01-28       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.